cvs caremark pbm - Search News

Big 3 PBMs reaped $7.3B from generic specialty drug markups: FTC

The Federal Trade Commission voted unanimously to release additional findings from its yearslong probe into CVS Caremark, OptumRx and Express Scripts.

The Financial Times · 1d

FTC says pharmacy benefits managers marked-up generic drug prices for $7.3bn gain

Regulator’s report finds companies ‘hiked costs’ for a range of medicines, including cancer and HIV treatments

U.S. News & World Report · 1d

US FTC Finds Major Pharmacy Benefit Managers Inflated Drug Prices for $7.3 Billion Gain

UnitedHealth Group's Optum, CVS Health's CVS Caremark and Cigna's Express Scripts -- marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 billion in revenue in excess of the acquisition costs of the drugs,

NBC News · 1d

Top three insurers reaped $7.3 billion through their drug middlemen's markups, FTC says

Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" prescription price hikes of 1,000% or more.

1don MSN

Snyders Pharmacy claims pressure from CVS, PBMs leads to shrinking services

As the director, he represents Snyders Pharmacy’s fourth generation. The 95-year-old chain spans the stateline from Oregon to ...

Healthcare Dive1d

FTC releases second report slamming pharmacy benefit managers

Agency commissioners voted unanimously on Tuesday to publish the report, which makes similar allegations against the ...

pharmaphorum1d

FTC doubles down on PBM criticism in new report

The new document focuses on the influence of PBMs over the market for specialty generic drugs for illnesses like cancer, ...

MedCity News9h

Healthcare Leaders Support FTC’s Second Report on PBMs, While PBMs Criticize Findings

On Tuesday, the Federal Trade Commission released its second interim staff report on prescription drug middlemen. The report ...

Latin Times on MSN2h

UnitedHealth Is Price Gouging Cancer Patients by Overcharging 'Thousands of Percent' for Live-Saving Meds, Pocketing Extra Billions: Feds

The UnitedHealth Group is overcharging patients for necessary life-saving drugs as a result of price gouging that increases ...

FOX 9 Minneapolis-St. Paul on MSN1d

FTC says Optum, other prescription benefit managers inflate cancer drug prices 1,000%

Prescription benefit managers have been under growing scrutiny from state and federal regulators who have accused them of ...

20hon MSN

UnitedHealth, employer of slain exec Brian Thompson, found to have overcharged some cancer patients for drugs by over 1,000%

The accused killer of Brian Thompson cited the industry’s failures as his motive for assassinating the UnitedHealth executive ...

23h

FTC report shows $7.3 billion in drug price inflation by leading pharmacy benefit managers

From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 ...

Star Tribune12d

Lawsuit in Minnesota deepens pharmacy benefit manager pushback against state regulations

The new lawsuit cites the fine as an example of how the Commerce Department has been “aggressively enforcing” the state’s PBM law. Following the consent order with CVS Caremark, the ...

CVS Health: Current Price Offers Favorable Risk-Reward Profile

The Health Care Benefits segment includes Aetna and other health insurance businesses. CVS acquired Aetna in 2017. In 2023, ...

Hosted on MSN23h

FTC Slams UnitedHealth (NYSE:UNH), CVS and Cigna PBMs for Inflating Prices by $7.3B

The U.S. Federal Trade Commission (FTC) has slammed pharmacy benefit managers (PBMs) owned by UnitedHealth ($UNH), CVS Health ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results